{
    "title": "Twin preterm neonates with cardiac toxicity related to lopinavir/ritonavir therapy.",
    "abst": "We report twin neonates who were born prematurely at 32 weeks of gestation to a mother with human immunodeficiency virus infection. One of the twins developed complete heart block and dilated cardiomyopathy related to lopinavir/ritonavir therapy, a boosted protease-inhibitor agent, while the other twin developed mild bradycardia. We recommend caution in the use of lopinavir/ritonavir in the immediate neonatal period.",
    "title_plus_abst": "Twin preterm neonates with cardiac toxicity related to lopinavir/ritonavir therapy. We report twin neonates who were born prematurely at 32 weeks of gestation to a mother with human immunodeficiency virus infection. One of the twins developed complete heart block and dilated cardiomyopathy related to lopinavir/ritonavir therapy, a boosted protease-inhibitor agent, while the other twin developed mild bradycardia. We recommend caution in the use of lopinavir/ritonavir in the immediate neonatal period.",
    "pubmed_id": "19820426",
    "entities": [
        [
            27,
            43,
            "cardiac toxicity",
            "Disease",
            "D066126"
        ],
        [
            55,
            74,
            "lopinavir/ritonavir",
            "Chemical",
            "C558899"
        ],
        [
            176,
            214,
            "human immunodeficiency virus infection",
            "Disease",
            "D015658"
        ],
        [
            252,
            263,
            "heart block",
            "Disease",
            "D006327"
        ],
        [
            268,
            290,
            "dilated cardiomyopathy",
            "Disease",
            "D002311"
        ],
        [
            302,
            321,
            "lopinavir/ritonavir",
            "Chemical",
            "C558899"
        ],
        [
            403,
            414,
            "bradycardia",
            "Disease",
            "D001919"
        ],
        [
            451,
            470,
            "lopinavir/ritonavir",
            "Chemical",
            "C558899"
        ]
    ],
    "split_sentence": [
        "Twin preterm neonates with cardiac toxicity related to lopinavir/ritonavir therapy.",
        "We report twin neonates who were born prematurely at 32 weeks of gestation to a mother with human immunodeficiency virus infection.",
        "One of the twins developed complete heart block and dilated cardiomyopathy related to lopinavir/ritonavir therapy, a boosted protease-inhibitor agent, while the other twin developed mild bradycardia.",
        "We recommend caution in the use of lopinavir/ritonavir in the immediate neonatal period."
    ],
    "if_txt_length_is_changed_flag": 0,
    "lines": [
        "D066126\tDisease\tcardiac toxicity\tTwin preterm neonates with <target> cardiac toxicity </target> related to lopinavir/ritonavir therapy .",
        "C558899\tChemical\tlopinavir/ritonavir\tTwin preterm neonates with cardiac toxicity related to <target> lopinavir/ritonavir </target> therapy .",
        "D015658\tDisease\thuman immunodeficiency virus infection\tWe report twin neonates who were born prematurely at 32 weeks of gestation to a mother with <target> human immunodeficiency virus infection </target> .",
        "D006327\tDisease\theart block\tOne of the twins developed complete <target> heart block </target> and dilated cardiomyopathy related to lopinavir/ritonavir therapy , a boosted protease-inhibitor agent , while the other twin developed mild bradycardia .",
        "D002311\tDisease\tdilated cardiomyopathy\tOne of the twins developed complete heart block and <target> dilated cardiomyopathy </target> related to lopinavir/ritonavir therapy , a boosted protease-inhibitor agent , while the other twin developed mild bradycardia .",
        "C558899\tChemical\tlopinavir/ritonavir\tOne of the twins developed complete heart block and dilated cardiomyopathy related to <target> lopinavir/ritonavir </target> therapy , a boosted protease-inhibitor agent , while the other twin developed mild bradycardia .",
        "D001919\tDisease\tbradycardia\tOne of the twins developed complete heart block and dilated cardiomyopathy related to lopinavir/ritonavir therapy , a boosted protease-inhibitor agent , while the other twin developed mild <target> bradycardia </target> .",
        "C558899\tChemical\tlopinavir/ritonavir\tWe recommend caution in the use of <target> lopinavir/ritonavir </target> in the immediate neonatal period ."
    ],
    "lines_lemma": [
        "D066126\tDisease\tcardiac toxicity\tTwin preterm neonate with <target> cardiac toxicity </target> related to lopinavir/ritonavir therapy .",
        "C558899\tChemical\tlopinavir/ritonavir\tTwin preterm neonate with cardiac toxicity related to <target> lopinavir/ritonavir </target> therapy .",
        "D015658\tDisease\thuman immunodeficiency virus infection\twe report twin neonate who be bear prematurely at 32 week of gestation to a mother with <target> human immunodeficiency virus infection </target> .",
        "D006327\tDisease\theart block\tone of the twin develop complete <target> heart block </target> and dilate cardiomyopathy related to lopinavir/ritonavir therapy , a boosted protease-inhibitor agent , while the other twin develop mild bradycardia .",
        "D002311\tDisease\tdilated cardiomyopathy\tone of the twin develop complete heart block and <target> dilated cardiomyopathy </target> related to lopinavir/ritonavir therapy , a boosted protease-inhibitor agent , while the other twin develop mild bradycardia .",
        "C558899\tChemical\tlopinavir/ritonavir\tone of the twin develop complete heart block and dilate cardiomyopathy related to <target> lopinavir/ritonavir </target> therapy , a boosted protease-inhibitor agent , while the other twin develop mild bradycardia .",
        "D001919\tDisease\tbradycardia\tone of the twin develop complete heart block and dilate cardiomyopathy related to lopinavir/ritonavir therapy , a boosted protease-inhibitor agent , while the other twin develop mild <target> bradycardia </target> .",
        "C558899\tChemical\tlopinavir/ritonavir\twe recommend caution in the use of <target> lopinavir/ritonavir </target> in the immediate neonatal period ."
    ]
}